Literature DB >> 7495492

Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes.

W Reith1, V Steimle, B Mach.   

Abstract

The complex pattern of expression of major histocompatibility complex (MHC) class II molecules plays an essential role in the control of the immune response. Our understanding of the molecular mechanisms controlling this expression has benefited greatly from the identification of the regulatory factors defective in two forms of a hereditary disease of MHC class II regulation: bare lymphocyte syndrome. This has also provided new tools for the experimental modulation of MHC class II expression.

Entities:  

Mesh:

Year:  1995        PMID: 7495492     DOI: 10.1016/0167-5699(95)80048-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  13 in total

1.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.

Authors:  S Bontron; C Ucla; B Mach; V Steimle
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

Authors:  A Muhlethaler-Mottet; L A Otten; V Steimle; B Mach
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

5.  The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.

Authors:  J D Fontes; B Jiang; B M Peterlin
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

6.  Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.

Authors:  A Wakkach; S Poea; E Chastre; C Gespach; F Lecerf; S De La Porte; S Tzartos; A Coulombe; S Berrih-Aknin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 7.  Cellular and molecular basis of immunodeficiencies: their consequences for the development and induction of the immune response.

Authors:  J Sterzl
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

8.  Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.

Authors:  R F Abu-Arja; B E Gonzalez; M R Jacobs; L Cabral; R Egler; J Auletta; J Arnold; K R Cooke
Journal:  Transpl Infect Dis       Date:  2014-07-04       Impact factor: 2.228

9.  RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom.

Authors:  P Emery; B Durand; B Mach; W Reith
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

10.  Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface.

Authors:  Khalid Sendide; Ala-Eddine Deghmane; Jean-Marc Reyrat; Amina Talal; Zakaria Hmama
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.